Updated September 18, 2018 This content is archived.
Research by Craig T. Werner, a postdoctoral fellow in pharmacology and toxicology, and David Dietz, PhD, professor and chair of pharmaoclogy and toxicology, shows that a class of proteins, for the first time, been shown to be effective in reducing relapse, or drug-seeking behaviors, in a preclinical study. "One of the greatest challenges with addiction is the persistent vulnerability to relapse," Werner said.
